↓ Skip to main content

Safety assessment of anticancer drugs in association with radiotherapy in metastatic malignant melanoma: a real-life report

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, February 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
22 Mendeley
Title
Safety assessment of anticancer drugs in association with radiotherapy in metastatic malignant melanoma: a real-life report
Published in
Cancer Chemotherapy and Pharmacology, February 2019
DOI 10.1007/s00280-019-03806-5
Pubmed ID
Authors

Emmanuelle Couty, Alexis Vallard, Sandrine Sotton, Sarra Ouni, Max-Adrien Garcia, Sophie Espenel, Chloe Rancoule, Majed Ben Mrad, Anne-Catherine Biron, Jean-Luc Perrot, Julien Langrand-Escure, Nicolas Magné

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 18%
Other 3 14%
Researcher 2 9%
Student > Bachelor 2 9%
Librarian 1 5%
Other 2 9%
Unknown 8 36%
Readers by discipline Count As %
Medicine and Dentistry 6 27%
Nursing and Health Professions 2 9%
Biochemistry, Genetics and Molecular Biology 1 5%
Computer Science 1 5%
Agricultural and Biological Sciences 1 5%
Other 0 0%
Unknown 11 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2020.
All research outputs
#16,049,105
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#1,859
of 2,501 outputs
Outputs of similar age
#223,842
of 355,136 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#10
of 28 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,136 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.